\
&
Contact us
\
&
Contact us
Published on | 3 years ago
ProgrammesThere are several platforms where a researcher can find hosts (both supervisors and institutions) for MSCA calls, and vacancies for positions in running MSCA projects. These platforms at the same time offer the possibility for institutions, industry and SMEs to publish hosting offers to attract researchers.
MSCA-NET Matchmaking platform offers advanced opportunities to find a partner or start a cooperation. This is a virtual platform to facilitate cooperation between all types of institutions, companies and researchers. A place where you can publish your profile, offer your hosting arrangements to attract talent and establish bilateral and multilateral meetings to prepare MSCA projects for the upcoming MSCA 2022 and 2023 calls. The platform will be available until May 2023.
The MSCA-NET Expressions of Interest (EOI) page will support institutions in attracting more MSCA fellows per MSCA calls. It is possible to publish an EOI by filling a form for the MSCA Action of interest: Postdoctoral Fellowship (PF); Non-academic Placement; Doctoral Network (DN); Staff Exchange (SE) and Cofund. The EOI will be published in the overview of all submitted EOIs.
On the Euraxess platform you can find among others vacancies for PhD and postdoctoral positions in MSCA projects and hosting offers for upcoming MSCA calls.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital Europe AI Continent Advanced Digital Skills Deployment: Best use of technologies
The European Commission has published a new round of calls under the Digital Europe programme. The submission period for the following call topics will open on 21 April 2026: Apply AI: Piloting AI-based image screening in medical centres Digital solutions for regulatory compliance through data Advanced Digital Skills for AI Uptake in Health... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
